Clinical Trial

Cannabis and Processing Emotions Study

Study acronym: CAPE
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this study is to test a causal neural mechanism of cannabis use-related problem recognition in individuals with severe cannabis use disorder using a non-invasive form of neuromodulation called transcranial magnetic stimulation (TMS). The main question it aims to answer is: -Does manipulating neural activity in the medial orbitofrontal cortex of the brain affect cannabis use-related problem recognition? Researchers will compare three forms of theta burst stimulation (TBS; sham, intermittent, and continuous) in each participant to see if manipulations in neural activity lead to changes in cannabis use-related problem recognition. Participants will complete a screening interview about their mental health and substance use history and complete four in-person laboratory sessions, which involve questionnaires, four brief magnetic resonance imaging (MRI) scans, three TBS sessions, and three electroencephalogram (EEG) sessions. Participants will also be asked to provide urine samples and take saliva and/or breathalyzer tests at some of the lab visits.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-04-01; most recent amendment 2026-05-05.
Status change: Not Yet Recruiting → Recruiting 2026-05-05
Trial Details
NCT Number NCT06907979
Lead Sponsor Auburn University
Collaborators: Society of Addiction Psychology, National Institute on Drug Abuse (NIDA)
Conditions Cannabis Use Disorder, Severe
Enrollment 24 participants
Start Date 2026-01-22
Primary Completion 2027-05 (estimated)
Study Completion 2027-05 (estimated)
Updated on ClinicalTrials.gov 2026-05-06